Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CorMedix Inc CRMD

Healthcare
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections... see more

Recent & Breaking News (NDAQ:CRMD)

CorMedix Inc. to Begin Trading on the Nasdaq Stock Exchange

GlobeNewswire January 21, 2021

CorMedix Inc. Announces FDA Decision That Advisory Committee Meeting for New Drug Application for Defencath is Not Needed

GlobeNewswire November 18, 2020

CorMedix Inc. Reports Third Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire November 5, 2020

CorMedix Appoints Greg Duncan to its Board of Directors

GlobeNewswire November 2, 2020

CorMedix Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on November 5

GlobeNewswire October 29, 2020

CorMedix to Participate in BIO Investor Forum Digital

GlobeNewswire October 8, 2020

CorMedix Appoints Paulo Costa to its Board of Directors

GlobeNewswire September 17, 2020

CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

GlobeNewswire September 9, 2020

CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Defencath

GlobeNewswire August 31, 2020

CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business Update

GlobeNewswire August 10, 2020

CorMedix Inc. to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 10

GlobeNewswire August 3, 2020

CorMedix Announces Pricing of $20M Public Offering of Common Stock

GlobeNewswire July 28, 2020

CorMedix Announces Proposed Public Offering of Common Stock

GlobeNewswire July 27, 2020

CorMedix Inc. Reports Submission of Defencath(TM) New Drug Application

GlobeNewswire July 8, 2020

CorMedix Inc. Reports First Quarter 2020 Financial Results and Provides Business Update

GlobeNewswire May 11, 2020

CorMedix Inc. Announces Appointment of Chief Financial Officer

GlobeNewswire May 11, 2020

CorMedix Hosting KOL Call on Antimicrobial Resistance, Catheter-Related Bloodstream Infections (CRBSIs), and the Potential for Neutrolin®

GlobeNewswire May 6, 2020

CorMedix Inc. to Report First Quarter 2020 Financial Results and Provide a Corporate Update on May 11

GlobeNewswire May 4, 2020

CorMedix Inc. Announces Contract Extension of Jack Armstrong as Executive Vice President and Head of Technical Operations

GlobeNewswire April 23, 2020

CorMedix Completes Sale of $5.5 Million of NOL Tax Benefits through New Jersey Technology Business Tax Certificate Transfer Program

GlobeNewswire April 22, 2020